<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39146373</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>8</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Comparative analysis of financial toxicity between SARS-CoV-2 infection and common comorbidities.</ArticleTitle><Pagination><StartPage>e0309116</StartPage><MedlinePgn>e0309116</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0309116</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0309116</ELocationID><Abstract><AbstractText>Financial toxicity is common in individuals with COVID-19 and Long COVID. However, the extent of financial toxicity experienced, in comparison to other common comorbidities, is uncertain. Contributing factors exacerbating financial challenges in Long COVID are also unclear. These knowledge gaps are addressed via a cross-sectional analysis utilizing data from the 2022 National Health Interview Survey (NHIS), a representative sample drawn from the United States. COVID-19 cases were identified through self-reported positive testing or physician diagnoses. Long COVID was defined as experiencing COVID-19-related symptoms for more than three months. Comorbidity was assessed based on self-reported diagnoses of ten doctor-diagnosed conditions (Yes/No). Financial toxicity was defined as having difficulty paying medical bills, cost-related medication nonadherence, delaying healthcare due to cost, and/or not obtained healthcare due to cost. A total of 27,492 NHIS 2022 respondents were included in our analysis, representing 253 million U.S. adults. In multivariable logistic regression models, adults with Long COVID (excluding respondents with COVID-19 but not Long COVID), showed increased financial toxicity compared to those with other comorbidities, such as epilepsy (OR [95% CI]: 1.69 [1.22, 2.33]), dementia (1.51 [1.01, 2.25]), cancer (1.43 [1.19, 1.71]) or respiratory/cardiovascular conditions (1.18 [1.00, 1.40]/1.23 [1.02, 1.47]). Long COVID-related financial toxicity was associated with female sex, age &lt;65 years, lack of medical insurance, current paid employment, residence region, food insecurity, fatigue, mild to severe depression symptoms experienced during the survey completion, visits to hospital emergency rooms, presence of arthritis, cardiovascular or respiratory conditions, and social activity limitations. In conclusion, American adults with Long COVID, but not those who had prior COVID-19 infection without Long COVID, exhibited a higher prevalence of financial toxicity compared to individuals with common comorbidities. Vulnerable populations were at greater risk for financial toxicity. These findings emphasize the importance of evaluating strategies to reduce economic burden and increase awareness of the effect of Long COVID-related financial toxicity on patient's healthcare and health status.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Su</LastName><ForeName>Han</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-5260-8139</Identifier><AffiliationInfo><Affiliation>School of Nursing, Vanderbilt University, Nashville, TN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Hilaire J</ForeName><Initials>HJ</Initials><AffiliationInfo><Affiliation>School of Nursing, University of Washington, Seattle, WA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Figuracion</LastName><ForeName>Karl Cristie</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Department of Radiation Oncology, School of Medicine, University of Washington, Seattle, WA, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Mayur Bipin</ForeName><Initials>MB</Initials><AffiliationInfo><Affiliation>Division of Trauma, Emergency General Surgery and Surgical Critical Care, Vanderbilt University Medical Center, Nashville, TN, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Critical Illness, Brain Dysfunction and Survivorship Center, Vanderbilt University Medical, Nashville, TN, United States of America.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Needham</LastName><ForeName>Dale M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Pulmonary and Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physical Medicine and Rehabilitation, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Outcomes After Critical Illness and Surgery (OACIS) Group, Johns Hopkins University, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Nursing, Johns Hopkins University, Baltimore, MD, United States of America.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015897" MajorTopicYN="Y">Comorbidity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017281" MajorTopicYN="N">Cost of Illness</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017048" MajorTopicYN="N">Health Care Costs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>13</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39146373</ArticleId><ArticleId IdType="pmc">PMC11326593</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0309116</ArticleId><ArticleId IdType="pii">PONE-D-24-17319</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO. WHO Coronavirus (COVID-19) Dashboard
2023.  [Available from: https://covid19.who.int</Citation></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al.. The prevalence and long-term health effects of Long Covid among hospitalised and non-hospitalised populations: A systematic review and meta-analysis. EClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Admon AJ, Iwashyna TJ, Kamphuis LA, Gundel SJ, Sahetya SK, Peltan ID, et al.. Assessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months. JAMA Netw Open. 2023;6(2):e2255795.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9929698</ArticleId><ArticleId IdType="pubmed">36787143</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022;226(9):1593&#x2013;607. doi: 10.1093/infdis/jiac136</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>The L. Long COVID: 3 years in. Lancet. 2023;401(10379):795. doi: 10.1016/S0140-6736(23)00493-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)00493-2</ArticleId><ArticleId IdType="pmc">PMC9998094</ArticleId><ArticleId IdType="pubmed">36906338</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue JK, Franko NM, McCulloch DJ, McDonald D, Magedson A, Wolf CR, et al.. Sequelae in Adults at 6 Months After COVID-19 Infection. JAMA Network Open. 2021;4(2):e210830&#x2013;e.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Trujillo KL, Safarpour A, Santillana M, Ognyanova K, Druckman J, et al.. Association of post&#x2013;COVID-19 condition symptoms and employment status. JAMA network open. 2023;6(2):e2256152&#x2013;e. doi: 10.1001/jamanetworkopen.2022.56152</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.56152</ArticleId><ArticleId IdType="pmc">PMC9932847</ArticleId><ArticleId IdType="pubmed">36790806</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumpias AM, Schwartzman D, Fleming O. Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis. BMC Health Services Research. 2022;22(1):1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9358916</ArticleId><ArticleId IdType="pubmed">35941617</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwashyna TJ, Kamphuis LA, Gundel SJ, Hope AA, Jolley S, Admon AJ, et al.. Continuing cardiopulmonary symptoms, disability, and financial toxicity 1 month after hospitalization for third&#x2010;wave COVID&#x2010;19: early results from a US nationwide cohort. Journal of hospital medicine. 2021;16(9):531&#x2013;7. doi: 10.12788/jhm.3660</Citation><ArticleIdList><ArticleId IdType="doi">10.12788/jhm.3660</ArticleId><ArticleId IdType="pubmed">34424190</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua K-P, Conti RM, Becker NV. Out-of-pocket spending for health care after COVID-19 hospitalization. The American journal of managed care. 2022;28(8):398. doi: 10.37765/ajmc.2022.88852</Citation><ArticleIdList><ArticleId IdType="doi">10.37765/ajmc.2022.88852</ArticleId><ArticleId IdType="pmc">PMC9826666</ArticleId><ArticleId IdType="pubmed">35981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B, Xie Y, Al-Aly Z. Postacute sequelae of COVID-19 at 2 years. Nature Medicine. 2023. doi: 10.1038/s41591-023-02521-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-023-02521-2</ArticleId><ArticleId IdType="pmc">PMC10504070</ArticleId><ArticleId IdType="pubmed">37605079</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang BZ, Creekmur B, Yoo MS, Broder B, Subject C, Sharp AL. Healthcare Utilization Among Patients Diagnosed with COVID-19 in a Large Integrated Health System. Journal of General Internal Medicine. 2022;37(4):830&#x2013;7. doi: 10.1007/s11606-021-07139-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-021-07139-z</ArticleId><ArticleId IdType="pmc">PMC8735886</ArticleId><ArticleId IdType="pubmed">34993879</ArticleId></ArticleIdList></Reference><Reference><Citation>Koumpias AM, Schwartzman D, Fleming O. Long-haul COVID: healthcare utilization and medical expenditures 6 months post-diagnosis. BMC Health Serv Res. 2022;22(1):1010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9358916</ArticleId><ArticleId IdType="pubmed">35941617</ArticleId></ArticleIdList></Reference><Reference><Citation>Tene L, Bergroth T, Eisenberg A, David SSB, Chodick G. Risk factors, health outcomes, healthcare services utilization, and direct medical costs of patients with long COVID. International Journal of Infectious Diseases. 2023;128:3&#x2013;10. doi: 10.1016/j.ijid.2022.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2022.12.002</ArticleId><ArticleId IdType="pubmed">36529373</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz GM, Bach K, Bobos P, Cheung A, D&#xe9;cary S, Goulding S, et al.. Understanding How Post-COVID-19 Condition Affects Adults and Health Care Systems. JAMA Health Forum. 2023;4(7):e231933. doi: 10.1001/jamahealthforum.2023.1933</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2023.1933</ArticleId><ArticleId IdType="pubmed">37418268</ArticleId></ArticleIdList></Reference><Reference><Citation>Hair NL, Urban C. Association of Severe COVID-19 and Persistent COVID-19 Symptoms With Economic Hardship Among US Families. JAMA Network Open. 2023;6(12):e2347318&#x2013;e. doi: 10.1001/jamanetworkopen.2023.47318</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.47318</ArticleId><ArticleId IdType="pmc">PMC10716716</ArticleId><ArticleId IdType="pubmed">38085541</ArticleId></ArticleIdList></Reference><Reference><Citation>EVALUATION TIFHMA. Global Burden of Disease (GBD)
2019.  [Available from: https://www.healthdata.org/research-analysis/gbd.</Citation></Reference><Reference><Citation>Cutler DM. The Costs of Long COVID. JAMA Health Forum. 2022;3(5):e221809-e. doi: 10.1001/jamahealthforum.2022.1809</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamahealthforum.2022.1809</ArticleId><ArticleId IdType="pubmed">36219031</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisu M, Martin MY. Financial toxicity: a common problem affecting patient care and health. Nature Reviews Disease Primers. 2022;8(1):7. doi: 10.1038/s41572-022-00341-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41572-022-00341-1</ArticleId><ArticleId IdType="pmc">PMC9731797</ArticleId><ArticleId IdType="pubmed">35145106</ArticleId></ArticleIdList></Reference><Reference><Citation>Pike J, Kompaniyets L, Lindley MC, Saydah S, Miller G. Direct Medical Costs Associated With Post-COVID-19 Conditions Among Privately Insured Children and Adults. Prev Chronic Dis. 2023;20:E06. doi: 10.5888/pcd20.220292</Citation><ArticleIdList><ArticleId IdType="doi">10.5888/pcd20.220292</ArticleId><ArticleId IdType="pmc">PMC9923935</ArticleId><ArticleId IdType="pubmed">36757854</ArticleId></ArticleIdList></Reference><Reference><Citation>Womer J, Sarma N, Hauschildt K, Caldwell E, Admon A, Hough C, et al.. Financial Toxicity Is Associated With Impaired Recovery After Severe COVID-19: Results From the BLUE-CORAL Study. B21 SUPPORTING PATIENTS AND FAMILIES THROUGH SERIOUS ILLNESS AND RECOVERY: American Thoracic Society; 2023. p. A2829-A.</Citation></Reference><Reference><Citation>Datta BK, Coughlin SS, Fazlul I, Pandey A. COVID-19 and health care&#x2013;related financial toxicity in the United States: Evidence from the 2022 National Health Interview Survey. American Journal of Infection Control. 2024;52(4):392&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37956731</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruengorn C, Awiphan R, Wongpakaran N, Wongpakaran T, Nochaiwong S, Outcomes H, et al.. Association of job loss, income loss, and financial burden with adverse mental health outcomes during coronavirus disease 2019 pandemic in Thailand: A nationwide cross&#x2010;sectional study. Depression and Anxiety. 2021;38(6):648&#x2013;60. doi: 10.1002/da.23155</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/da.23155</ArticleId><ArticleId IdType="pmc">PMC8251094</ArticleId><ArticleId IdType="pubmed">33793028</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R, Jacob QM, Raj Eliza S, Mini M, Jose J. Financial burden and catastrophic health expenditure associated with COVID-19 hospitalizations in kerala, south India. ClinicoEconomics and Outcomes Research. 2022:439&#x2013;46. doi: 10.2147/CEOR.S365999</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CEOR.S365999</ArticleId><ArticleId IdType="pmc">PMC9270006</ArticleId><ArticleId IdType="pubmed">35813122</ArticleId></ArticleIdList></Reference><Reference><Citation>Faramarzi A, Norouzi S, Dehdarirad H, Aghlmand S, Yusefzadeh H, Javan-Noughabi J. The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis. Systematic Reviews. 2024;13(1):68. doi: 10.1186/s13643-024-02476-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13643-024-02476-6</ArticleId><ArticleId IdType="pmc">PMC10870589</ArticleId><ArticleId IdType="pubmed">38365735</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics NCfH. National Health Interview Survey, 2022. Public-use data file and documentation. 2023 [Available from: https://www.cdc.gov/nchs/nhis/2022nhis.htm</Citation></Reference><Reference><Citation>Statistics. NCfH. National Health Interview Survey, 2022.  survey description. 2023 [Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2022/srvydesc-508.pdf</Citation></Reference><Reference><Citation>Statistics NCfH. Preferred Reporting Items for Complex Sample Survey Analysis (PRICSSA)
2022.  National Health Interview Survey 2023 [Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2022/2022-NHIS-PRICSSA-508.pdf.</Citation></Reference><Reference><Citation>Organization WH. Post COVID-19 condition (Long COVID)
2022.  [cited 2023 December 19]. Available from: https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition.</Citation></Reference><Reference><Citation>Lederer DJ, Bell SC, Branson RD, Chalmers JD, Marshall R, Maslove DM, et al.. Control of Confounding and Reporting of Results in Causal Inference Studies. Guidance for Authors from Editors of Respiratory, Sleep, and Critical Care Journals. Ann Am Thorac Soc. 2019;16(1):22&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30230362</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics NCfH. NCHS Urban-Rural Classification Scheme for Counties. 2013.</Citation></Reference><Reference><Citation>Bickel G, Nord M, Price C, Hamilton W, Cook J. Guide to measuring household food security, revised 2000. 2000.</Citation></Reference><Reference><Citation>Valero-Elizondo J, Chouairi F, Khera R, Grandhi GR, Saxena A, Warraich HJ, et al.. Atherosclerotic Cardiovascular Disease, Cancer, and Financial Toxicity Among Adults in the United States. JACC CardioOncol. 2021;3(2):236&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352280</ArticleId><ArticleId IdType="pubmed">34396329</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer M, Harley D. Models and measurement in disability: an international review. Health Policy and Planning. 2012;27(5):357&#x2013;64. doi: 10.1093/heapol/czr047</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/heapol/czr047</ArticleId><ArticleId IdType="pubmed">21729911</ArticleId></ArticleIdList></Reference><Reference><Citation>United Nations Statistics Division Washington Group on Disability Statistics Homepage. [Available from: https://unstats.un.org/unsd/methods/citygroup/washington.htm.</Citation></Reference><Reference><Citation>Chan KT, Algood C, Prifti A, Zidan T. Cross-Cultural Measurement Invariance of a Measure of Disability for White, Black, Hispanic and Asian Older Adults. Int J Environ Res Public Health. 2021;18(4). doi: 10.3390/ijerph18041401</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18041401</ArticleId><ArticleId IdType="pmc">PMC7913295</ArticleId><ArticleId IdType="pubmed">33546272</ArticleId></ArticleIdList></Reference><Reference><Citation>Statistics WGoD. An introduction to the Washington Group on Disability Statistics question sets. [Available from: https://www.washingtongroupdisability.com/fileadmin/uploads/wg/Documents/Primer.pdf.</Citation></Reference><Reference><Citation>Rutter LA, Brown TA. Psychometric properties of the generalized anxiety disorder scale-7 (GAD-7) in outpatients with anxiety and mood disorders. Journal of psychopathology and behavioral assessment. 2017;39:140&#x2013;6. doi: 10.1007/s10862-016-9571-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10862-016-9571-9</ArticleId><ArticleId IdType="pmc">PMC5333929</ArticleId><ArticleId IdType="pubmed">28260835</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorndike RM. Book review: psychometric theory by Jum Nunnally and Ira Bernstein New York: McGraw-hill, 1994, xxiv+ 752 pp. Applied psychological measurement. 1995;19(3):303&#x2013;5.</Citation></Reference><Reference><Citation>Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. Journal of affective disorders. 2009;114(1&#x2013;3):163&#x2013;73. doi: 10.1016/j.jad.2008.06.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2008.06.026</ArticleId><ArticleId IdType="pubmed">18752852</ArticleId></ArticleIdList></Reference><Reference><Citation>Pressler SJ, Subramanian U, Perkins SM, Gradus-Pizlo I, Kareken D, Kim J, et al.. Measuring depressive symptoms in heart failure: validity and reliability of the patient health questionnaire-8. Am J Crit Care. 2011;20(2):146&#x2013;52. doi: 10.4037/ajcc2010931</Citation><ArticleIdList><ArticleId IdType="doi">10.4037/ajcc2010931</ArticleId><ArticleId IdType="pubmed">20378777</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JE, Lou VW, Jian H, Zhou Z, Yan M, Zhu J, et al.. Objective and subjective financial burden and its associations with health-related quality of life among lung cancer patients. Supportive Care in Cancer. 2018;26(4):1265&#x2013;72. doi: 10.1007/s00520-017-3949-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00520-017-3949-4</ArticleId><ArticleId IdType="pubmed">29105024</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NH, Khera R, Ohno-Machado L, Sandborn WJ, Singh S. Prevalence and effects of food insecurity and social support on financial toxicity in and healthcare use by patients with inflammatory bowel diseases. Clinical Gastroenterology and Hepatology. 2021;19(7):1377&#x2013;86. e5. doi: 10.1016/j.cgh.2020.05.056</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cgh.2020.05.056</ArticleId><ArticleId IdType="pmc">PMC7987215</ArticleId><ArticleId IdType="pubmed">32526341</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor KK, Neiman PU, Liu C, Sheetz K, Sinco B, Scott JW. Financial Toxicity Among Surgical Patients Varies by Income and Insurance: A Cross-sectional Analysis of the National Health Interview Survey. Ann Surg. 2022;276(1):e56&#x2013;e8. doi: 10.1097/SLA.0000000000005382</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SLA.0000000000005382</ArticleId><ArticleId IdType="pubmed">35129477</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Lee S, Heeringa SG. Population Weighting in Statistical Analysis. JAMA Internal Medicine. 2023.</Citation><ArticleIdList><ArticleId IdType="pubmed">38010717</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al.. Risk factors associated with Post&#x2212; COVID-19 condition: a systematic review and meta-analysis. JAMA Internal Medicine. 2023. doi: 10.1001/jamainternmed.2023.0750</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Harry C, Sanara R, Joseph N, Megan Y, Paul E. Long covid&#x2014;mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583&#x2013;90. doi: 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2013;21. doi: 10.1016/S2213-8587(22)00044-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-8587(22)00044-4</ArticleId><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S, Lee H, Lee J, Lee SW, Kwon R, Kim MS, et al.. Short- and long-term neuropsychiatric outcomes in long COVID in South Korea and Japan. Nat Hum Behav. 2024. doi: 10.1038/s41562-024-01895-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41562-024-01895-8</ArticleId><ArticleId IdType="pubmed">38918517</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi Y, Kim HJ, Park J, Lee M, Kim S, Koyanagi A, et al.. Acute and post-acute respiratory complications of SARS-CoV-2 infection: population-based cohort study in South Korea and Japan. Nat Commun. 2024;15(1):4499. doi: 10.1038/s41467-024-48825-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-48825-w</ArticleId><ArticleId IdType="pmc">PMC11130304</ArticleId><ArticleId IdType="pubmed">38802352</ArticleId></ArticleIdList></Reference><Reference><Citation>Gualano MR, Rossi MF, Borrelli I, Santoro PE, Amantea C, Daniele A, et al.. Returning to work and the impact of post COVID-19 condition: A systematic review. Work. 2022;73(2):405&#x2013;13. doi: 10.3233/WOR-220103</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-220103</ArticleId><ArticleId IdType="pubmed">35938280</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaidan M, Puebla Neira D, Polychronopoulou E, Yong-Fang K, Sharma G. Healthcare utilization 9 months pre- and post- COVID-19 hospitalization among patients discharged alive. PLoS One. 2024;19(6):e0303509. doi: 10.1371/journal.pone.0303509</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0303509</ArticleId><ArticleId IdType="pmc">PMC11189225</ArticleId><ArticleId IdType="pubmed">38900737</ArticleId></ArticleIdList></Reference><Reference><Citation>Khera R, Valero-Elizondo J, Nasir K. Financial Toxicity in Atherosclerotic Cardiovascular Disease in the United States: Current State and Future Directions. J Am Heart Assoc. 2020;9(19):e017793. doi: 10.1161/JAHA.120.017793</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/JAHA.120.017793</ArticleId><ArticleId IdType="pmc">PMC7792407</ArticleId><ArticleId IdType="pubmed">32924728</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel MR, Jagsi R, Resnicow K, Smith SN, Hamel LM, Su C, et al.. A Scoping Review of Behavioral Interventions Addressing Medical Financial Hardship. Popul Health Manag. 2021;24(6):710&#x2013;21. doi: 10.1089/pop.2021.0043</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/pop.2021.0043</ArticleId><ArticleId IdType="pmc">PMC8713277</ArticleId><ArticleId IdType="pubmed">33989065</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar SY. Financial Toxicity of Cancer Care: It&#x2019;s Time to Intervene. J Natl Cancer Inst. 2016;108(5). doi: 10.1093/jnci/djv370</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jnci/djv370</ArticleId><ArticleId IdType="pubmed">26657334</ArticleId></ArticleIdList></Reference><Reference><Citation>Graves JA, Baig K, Buntin M. The Financial Effects and Consequences of COVID-19: A Gathering Storm. JAMA. 2021;326(19):1909&#x2013;10. doi: 10.1001/jama.2021.18863</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.18863</ArticleId><ArticleId IdType="pubmed">34714325</ArticleId></ArticleIdList></Reference><Reference><Citation>King JS. Covid-19 and the Need for Health Care Reform. N Engl J Med. 2020;382(26):e104. doi: 10.1056/NEJMp2000821</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2000821</ArticleId><ArticleId IdType="pubmed">32302074</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al.. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9). doi: 10.1136/bmjgh-2021-005427</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>King JS. Covid-19 and the need for health care reform. New England Journal of Medicine. 2020;382(26):e104. doi: 10.1056/NEJMp2000821</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp2000821</ArticleId><ArticleId IdType="pubmed">32302074</ArticleId></ArticleIdList></Reference><Reference><Citation>Blumberg SJ, Parker JD, Moyer BC. National Health Interview Survey, COVID-19, and Online Data Collection Platforms: Adaptations, Tradeoffs, and New Directions. Am J Public Health. 2021;111(12):2167&#x2013;75. doi: 10.2105/AJPH.2021.306516</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2021.306516</ArticleId><ArticleId IdType="pmc">PMC8667832</ArticleId><ArticleId IdType="pubmed">34878857</ArticleId></ArticleIdList></Reference><Reference><Citation>Bramlett DJ MD, Bose J, Blumberg SJ. New procedures for nonresponse adjustments to the 2019 National Health Interview Survey sampling weights.:
National Center for Health Statistics; 2020.  [Available from: https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Dataset_Documentation/NHIS/2019/nonresponse-report-508.pdf.</Citation></Reference><Reference><Citation>Fernandez-de-Las-Pe&#xf1;as C, Notarte KI, Macasaet R, Velasco JV, Catahay JA, Ver AT, et al.. Persistence of post-COVID symptoms in the general population two years after SARS-CoV-2 infection: A systematic review and meta-analysis. J Infect. 2024;88(2):77&#x2013;88. doi: 10.1016/j.jinf.2023.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2023.12.004</ArticleId><ArticleId IdType="pubmed">38101521</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al.. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: A systematic review. EClinicalMedicine. 2022;53:101624. doi: 10.1016/j.eclinm.2022.101624</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101624</ArticleId><ArticleId IdType="pmc">PMC9417563</ArticleId><ArticleId IdType="pubmed">36051247</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Torres-Macho J, Catahay JA, Macasaet R, Velasco JV, Macapagal S, et al.. Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review. Infection. 2024;52(1):43&#x2013;58. doi: 10.1007/s15010-023-02154-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02154-0</ArticleId><ArticleId IdType="pubmed">38113020</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>